Net Income (Loss) Attributable to Parent in USD of PLIANT THERAPEUTICS, INC. from Q1 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
PLIANT THERAPEUTICS, INC. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q1 2019 to Q3 2025.
  • PLIANT THERAPEUTICS, INC. Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was -$26.3M, a 54.5% increase year-over-year.
  • PLIANT THERAPEUTICS, INC. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2025 was -$175M, a 13% increase year-over-year.
  • PLIANT THERAPEUTICS, INC. annual Net Income (Loss) Attributable to Parent for 2024 was -$210M, a 30.4% decline from 2023.
  • PLIANT THERAPEUTICS, INC. annual Net Income (Loss) Attributable to Parent for 2023 was -$161M, a 30.8% decline from 2022.
  • PLIANT THERAPEUTICS, INC. annual Net Income (Loss) Attributable to Parent for 2022 was -$123M, a 26.8% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

PLIANT THERAPEUTICS, INC. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$175M -$26.3M +$31.5M +54.5% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025
Q2 2025 -$207M -$43.3M +$12.6M +22.5% 01 Apr 2025 30 Jun 2025 10-Q 06 Nov 2025
Q1 2025 -$220M -$56.2M -$9.21M -19.6% 01 Jan 2025 31 Mar 2025 10-Q 06 Nov 2025
Q4 2024 -$210M -$49.7M -$8.62M -21% 01 Oct 2024 31 Dec 2024 10-K 03 Mar 2025
Q3 2024 -$202M -$57.8M -$16.3M -39.2% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025
Q2 2024 -$185M -$55.9M -$14.7M -35.6% 01 Apr 2024 30 Jun 2024 10-Q 06 Nov 2025
Q1 2024 -$171M -$47M -$9.41M -25.1% 01 Jan 2024 31 Mar 2024 10-Q 06 Nov 2025
Q4 2023 -$161M -$41.1M -$6.05M -17.3% 01 Oct 2023 31 Dec 2023 10-K 03 Mar 2025
Q3 2023 -$155M -$41.5M -$10.9M -35.5% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024
Q2 2023 -$144M -$41.2M -$11.6M -39.4% 01 Apr 2023 30 Jun 2023 10-Q 07 Nov 2024
Q1 2023 -$133M -$37.5M -$9.45M -33.6% 01 Jan 2023 31 Mar 2023 10-Q 07 Nov 2024
Q4 2022 -$123M -$35.1M -$10.5M -42.9% 01 Oct 2022 31 Dec 2022 10-K 03 Mar 2025
Q3 2022 -$113M -$30.6M -$3.57M -13.2% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 -$109M -$29.5M -$6.72M -29.4% 01 Apr 2022 30 Jun 2022 10-Q 09 Nov 2023
Q1 2022 -$103M -$28.1M -$5.24M -22.9% 01 Jan 2022 31 Mar 2022 10-Q 09 Nov 2023
Q4 2021 -$97.3M -$24.5M -$5.5M -28.9% 01 Oct 2021 31 Dec 2021 10-K 27 Feb 2024
Q3 2021 -$91.8M -$27M -$10.5M -63.6% 01 Jul 2021 30 Sep 2021 10-Q 08 Nov 2022
Q2 2021 -$81.2M -$22.8M -$5.83M -34.3% 01 Apr 2021 30 Jun 2021 10-Q 08 Nov 2022
Q1 2021 -$75.4M -$22.9M -$33.9M -307% 01 Jan 2021 31 Mar 2021 10-Q 08 Nov 2022
Q4 2020 -$41.5M -$19M -$61.2M -145% 01 Oct 2020 31 Dec 2020 10-K 01 Mar 2022
Q3 2020 $19.7M -$16.5M -$3.28M -24.7% 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021
Q2 2020 $22.9M -$17M -$1.48M -9.53% 01 Apr 2020 30 Jun 2020 10-Q 09 Nov 2021
Q1 2020 $24.4M $11M +$25.1M 01 Jan 2020 31 Mar 2020 10-Q 09 Nov 2021
Q4 2019 -$631K $42.2M 01 Oct 2019 31 Dec 2019 10-K 01 Mar 2022
Q3 2019 -$13.3M 01 Jul 2019 30 Sep 2019 10-Q 10 Nov 2020
Q2 2019 -$15.5M 01 Apr 2019 30 Jun 2019 10-Q 10 Nov 2020
Q1 2019 -$14M 01 Jan 2019 31 Mar 2019 10-Q 10 Nov 2020

PLIANT THERAPEUTICS, INC. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$210M -$49M -30.4% 01 Jan 2024 31 Dec 2024 10-K 03 Mar 2025
2023 -$161M -$38M -30.8% 01 Jan 2023 31 Dec 2023 10-K 03 Mar 2025
2022 -$123M -$26.1M -26.8% 01 Jan 2022 31 Dec 2022 10-K 03 Mar 2025
2021 -$97.3M -$55.7M -134% 01 Jan 2021 31 Dec 2021 10-K 27 Feb 2024
2020 -$41.5M -$40.9M -6482% 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2022
2019 -$631K 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.